» Articles » PMID: 10871848

P53-independent Apoptosis Associated with C-Myc-mediated Block in Myeloid Cell Differentiation

Overview
Journal Oncogene
Date 2000 Jun 29
PMID 10871848
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Previously we have shown that deregulated expression of c-myc in M1 myeloid leukemic cells blocked IL-6-induced differentiation and its associated growth arrest; however, the cells proliferated at a significantly reduced rate compared to untreated cells. The basis for the increased doubling time of IL-6-treated M1myc cells was found to be due to the induction of a p53-independent apoptotic pathway. The apoptotic response was not completely penetrant; in the same population of cells both proliferation and apoptosis were continuously ongoing. Down-regulation of Bcl-2 was insufficient to account for the apoptotic response, since deregulated expression of Bcl-2 delayed, but did not block, the onset of apoptosis. Furthermore, our results indicated that the IL-6-induced partial hypophosphorylation of the retinoblastoma gene product (Rb), observed in M1myc cells, was not responsible for the apoptotic response. Finally, the findings in M1 cells were extended to myeloid cells derived from the bone marrow of wild type and p53-deficient mice, where the deregulated expression of c-myc was also shown to block terminal differentiation and induce apoptosis independent of p53. These findings provide new insights into how myc participates in the neoplastic process, and how additional mutations can promote more aggressive tumors. Oncogene (2000) 19, 2967 - 2977

Citing Articles

Tissue- and cell-specific properties of enterochromaffin cells affect the fate of tumorigenesis toward nonendocrine adenocarcinoma of the small intestine.

Sei Y, Feng J, Zhao X, Dagur P, McCoy J, Merchant J Am J Physiol Gastrointest Liver Physiol. 2022; 324(3):G177-G189.

PMID: 36537709 PMC: 9925174. DOI: 10.1152/ajpgi.00205.2022.


Myc-Miz1 signaling promotes self-renewal of leukemia stem cells by repressing Cebpα and Cebpδ.

Zhang L, Li J, Xu H, Shao X, Fu L, Hou Y Blood. 2020; 135(14):1133-1145.

PMID: 32040550 PMC: 9981456. DOI: 10.1182/blood.2019001863.


Family matters: How MYC family oncogenes impact small cell lung cancer.

Bragelmann J, Bohm S, Guthrie M, Mollaoglu G, Oliver T, Sos M Cell Cycle. 2017; 16(16):1489-1498.

PMID: 28737478 PMC: 5584863. DOI: 10.1080/15384101.2017.1339849.


MYC, Cell Competition, and Cell Death in Cancer: The Inseparable Triad.

Di Giacomo S, Sollazzo M, Paglia S, Grifoni D Genes (Basel). 2017; 8(4).

PMID: 28420161 PMC: 5406867. DOI: 10.3390/genes8040120.


Jungermannenone A and B induce ROS- and cell cycle-dependent apoptosis in prostate cancer cells in vitro.

Guo Y, Lin Z, Wang M, Dong Y, Niu H, Young C Acta Pharmacol Sin. 2016; 37(6):814-24.

PMID: 27133304 PMC: 4954765. DOI: 10.1038/aps.2016.26.